Unknown

Dataset Information

0

SAR Studies of N-[2-(1H-Tetrazol-5-yl)phenyl]benzamide Derivatives as Potent G Protein-Coupled Receptor-35 Agonists.

ABSTRACT: G protein-coupled receptor-35 (GPR35) has emerged as a potential target in the treatment of pain and inflammatory and metabolic diseases. We have discovered a series of potent GPR35 agonists based on a coumarin scaffold and found that the introduction of a 1H-tetrazol-5-yl group significantly increased their potency. We designed and synthesized a new series of N-[2-(1H-tetrazol-5-yl)phenyl]benzamide derivatives through a two-step synthetic approach, and characterized their agonistic activities against GPR35 using a dynamic mass redistribution (DMR) assay. N-(5-bromo-2-(1H-tetrazol-5-yl)phenyl)-4-methoxybenzamide (56) and N-(5-bromo-2-(1H-tetrazol-5-yl)phenyl)-2-fluoro-4-methoxybenzamide (63) displayed the highest agonistic potency agonist GPR35 with an EC50 of 0.059 μM and 0.041 μM, respectively. The physicochemical properties of selected compounds were calculated to evaluate their druglikeness, suggesting that compounds 56 and 63 have good druglike properties. Together, N-[2-(1H-tetrazol-5-yl)phenyl]benzamide derivatives are potentially great candidates for developing potent GPR35 agonists.

SUBMITTER: Wei L 

PROVIDER: S-EPMC5949814 | biostudies-other | 2018 May

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

SAR Studies of <i>N</i>-[2-(1<i>H</i>-Tetrazol-5-yl)phenyl]benzamide Derivatives as Potent G Protein-Coupled Receptor-35 Agonists.

Wei Lai L   Hou Tao T   Lu Chang C   Wang Jixia J   Zhang Xiuli X   Fang Ye Y   Zhao Yaopeng Y   Feng Jiatao J   Li Jiaqi J   Qu Lala L   Piao Hai-Long HL   Liang Xinmiao X  

ACS medicinal chemistry letters 20180409 5

G protein-coupled receptor-35 (GPR35) has emerged as a potential target in the treatment of pain and inflammatory and metabolic diseases. We have discovered a series of potent GPR35 agonists based on a coumarin scaffold and found that the introduction of a 1<i>H-</i>tetrazol-5-yl group significantly increased their potency. We designed and synthesized a new series of <i>N-</i>[2-(1<i>H-</i>tetrazol-5-yl)phenyl]benzamide derivatives through a two-step synthetic approach, and characterized their a  ...[more]

Similar Datasets

Unknown N-(2-Oxo-2-phenyl-acet-yl)benzamide.
| S-EPMC3050373 | biostudies-literature
Transcriptomics RNA sequencing of murine C2C12 cell treated with high-throughput screening hit compound 6,8-dimethyl-3-(4-phenyl-1H-imidazol-5-yl)quinolin-2(1H)-one.
2020-01-15 | GSE125052 | GEO
Unknown N-(4-Methyl-phenyl-sulfon-yl)-3-nitro-benzamide.
| S-EPMC3998341 | biostudies-literature
Unknown N-(4-Acetyl-3-methyl-1-phenyl-1H-pyrazol-5-yl)-N-methyl-2-(2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)benzamide.
| S-EPMC3790439 | biostudies-literature
Unknown Fluorinated 1-phenyl-1H-tetrazol-5-yl sulfone derivatives as general reagents for fluoroalkylidene synthesis.
| S-EPMC3045538 | biostudies-literature
Unknown Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents.
| S-EPMC5486227 | biostudies-literature
Unknown Ethyl 2-[(phenyl-sulfan-yl)meth-yl]-1-(phenyl-sulfon-yl)-1H-indole-3-carboxyl-ate.
| S-EPMC2960260 | biostudies-literature
Unknown Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
| S-EPMC4025658 | biostudies-literature
Unknown Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists.
| S-EPMC9639781 | biostudies-literature
Unknown Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor.
| S-EPMC4569879 | biostudies-literature